Hmmm, though not much excitement or volume. In the age of t-cell treatments etc, Bisantrene is kind of old school. Hopefully this trial in Israel can generate the sort of AML results achieved all those years ago.
Honestly, it's the low MC that's a large part of my attraction to this one, I'm just not sure how much it's swaying my judgement.
I never looked into how it dropped off the radar and got shelved. Can anyone give me a quick summary?
Cheers
30 cent target, page-8
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
0.050(3.15%) |
Mkt cap ! $278.7M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.65 | $1.57 | $98.54K | 60.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2377 | $1.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 320 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |